The role of leukocytes in thrombosis

LL Swystun, PC Liaw - Blood, The Journal of the American …, 2016 - ashpublications.org
In recent years, the traditional view of the hemostatic system as being regulated by a
coagulation factor cascade coupled with platelet activation has been increasingly …

Platelet-derived chemokines in inflammation and atherosclerosis

C Bakogiannis, M Sachse, K Stamatelopoulos… - Cytokine, 2019 - Elsevier
Platelets are inflammatory anuclear cells with a well-established role in the development
and manifestation of atherosclerosis. Activated platelets secrete a plethora of chemokines …

Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19

ED Hottz, IG Azevedo-Quintanilha… - Blood, The Journal …, 2020 - ashpublications.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent pathogen
responsible for the coronavirus disease 2019 (COVID-19). Since its emergence, the novel …

Extracellular vesicles and thrombosis: update on the clinical and experimental evidence

K Zifkos, C Dubois, K Schäfer - International Journal of Molecular …, 2021 - mdpi.com
Extracellular vesicles (EVs) compose a heterogenous group of membrane-derived particles,
including exosomes, microvesicles and apoptotic bodies, which are released into the …

Where the action is—leukocyte recruitment in atherosclerosis

C Mauersberger, J Hinterdobler… - Frontiers in …, 2022 - frontiersin.org
Atherosclerosis is the leading cause of death worldwide and leukocyte recruitment is a key
element of this phenomenon, thus allowing immune cells to enter the arterial wall. There, in …

Pathophysiology of coagulation and emerging roles for extracellular vesicles in coagulation cascades and disorders

H Al-Koussa, I AlZaim, ME El-Sabban - Journal of clinical medicine, 2022 - mdpi.com
The notion of blood coagulation dates back to the ancient Greek civilization. However, the
emergence of innovative scientific discoveries that started in the seventeenth century …

Platelet-derived extracellular vesicles as target of antiplatelet agents. What is the evidence?

F Taus, A Meneguzzi, M Castelli, P Minuz - Frontiers in pharmacology, 2019 - frontiersin.org
Platelet-derived large extracellular vesicles (often referred to as microparticles in the field of
cardiovascular disease) have been identified as effector in the atherothrombotic process …

Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity

L Jesel, M Abbas, F Toti, A Cohen, T Arentz… - International journal of …, 2013 - Elsevier
Microparticles (MPs) are small membrane vesicles that are shed from virtually all cells in
response to stress. Widely described in atherothrombotic diseases, recent data suggest a …

In vitro models for thrombogenicity testing of blood-recirculating medical devices

DN Sarode, S Roy - Expert review of medical devices, 2019 - Taylor & Francis
Introduction: Blood-recirculating medical devices, such as mechanical circulatory support
(MCS), extracorporeal membrane oxygenators (ECMO), and hemodialyzers, are commonly …

Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis

T Petzold, M Thienel, I Konrad, I Schubert… - Science translational …, 2016 - science.org
In patients with atrial fibrillation, oral anticoagulation with oral thrombin inhibitors (OTIs), in
contrast to vitamin K antagonists (VKAs), associates with a modest increase in acute …